Episode Details
Back to EpisodesShould I Invest in SpaceX? (Lessons from SpaceX IPO)
Episode 285
Published 2 weeks ago
Description
SpaceX priced at $135 a share, raised $75 billion, and hit an all-time high of $225 within days — then fell to $107. Dr. Jimmy Turner and Justin Harvey CFP break down how index funds actually decide what gets included in the index, why the S&P 500 said no to SpaceX while CRSP and the Russell 1000 said yes, and what that means for the total stock market index fund in your 401(k).
What you'll learn:
- Why an index fund doesn't pick stocks — it follows 3 rules: seasoning, profitability, and float
- How Nasdaq, Russell 1000, and CRSP cut IPO seasoning for SpaceX
- Why your money in an IPO often funds the private investors cashing out on the other side
- What Dimensional's 12-month IPO exclusion says about buying at the offering
- How to handle FOMO before Anthropic and OpenAI potentially go public
Resources mentioned:
- Looking to lower your taxes? Check out Gelt, the tax team Jimmy uses: https://moneymeetsmedicine.com/CPA
- Juno — Looking for a lower interest rate on your student loans? Use group negotiated rates from Juno here: moneymeetsmedicine.com/juno
- Every physician needs disability insurance. Get quotes from Money Meets Medicine Disability Insurance: https://moneymeetsmedicine.com/disability
- The Physician Philosopher's Guide to Personal Finance — free book for physicians — moneymeetsmedicine.com/freebook
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.